DeepMed Research

University Hospital Geneva Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms

Recruiting

Conditions: Intracranial Aneurysm

First Posted Date: 2022-09-02

Last Posted Date: 2024-08-27

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 20000

Registration Number: NCT05526352

Locations: 🇺🇸
University of Virginia, Virginia Beach, Virginia, United States
🇳🇱
Erasmus Medical Center, Rotterdam, Netherlands
🇵🇱
Jagiellonian University Medical College, Cracovia, Poland

and more 16 locations

Dynamic Response to Probiotics in Context of Alzheimer Disease: a Proof-of-concept Study

Not Applicable

Completed

Conditions: Alzheimer Disease

Interventions: Dietary Supplement: SLAB51

First Posted Date: 2022-08-30

Last Posted Date: 2025-01-23

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 3

Registration Number: NCT05521477

Locations: 🇨🇭
Geneva University hospitals - Memory clinic, Geneva, Switzerland

One-time Informed Consent for Research in Prison

Not Applicable

Completed

Conditions: Informed Consent

Interventions: Behavioral: Audio-visual material

First Posted Date: 2022-08-17

Last Posted Date: 2022-08-17

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 290

Registration Number: NCT05505058

Locations: 🇨🇭
Division of prison health, Geneva, Switzerland

BIOSTEMI Extended Survival

Completed

Conditions: Coronary Artery Disease
Acute Coronary Syndrome

First Posted Date: 2022-08-02

Last Posted Date: 2023-11-29

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 1300

Registration Number: NCT05484310

Locations: 🇨🇭
Inselspital, Bern University Hospital, Bern, Switzerland
🇨🇭
Basel University Hospital, Basel, Switzerland
🇨🇭
Kantonsspital Luzern, Luzern, Switzerland

and more 7 locations

Telecytology as a Triage Tool in LMICs

Completed

Conditions: Cervical Cancer

First Posted Date: 2022-07-26

Last Posted Date: 2025-01-29

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 30

Registration Number: NCT05474404

Locations: 🇨🇭
University Hospitals Geneva, Geneva, Switzerland

Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)

Phase 3

Recruiting

Conditions: Sickle Cell Disease
Hyperbaric Oxygen Therapy
Vaso-occlusive Crisis

Interventions: Device: HBOT in Hyperbaric chamber
Device: Hyperbaric chamber for placebo

First Posted Date: 2022-03-21

Last Posted Date: 2022-11-02

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 100

Registration Number: NCT05289700

Locations: 🇫🇷
Centre de compétences Sd drépanocytaires, Toulouse, France
🇫🇷
Hospices civils de Lyon, Lyon, France
🇨🇭
HUG, Geneva, Switzerland

Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status

Phase 1

Recruiting

Conditions: Healthy

Interventions: Drug: Voriconazole 200mg
Drug: FluvoxaMINE 50 Mg Oral Tablet
Drug: Omeprazole 10 MG Oral Tablet

First Posted Date: 2022-03-03

Last Posted Date: 2022-11-03

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 45

Registration Number: NCT05264142

Locations: 🇨🇭
Geneva University Hospitals, HUG, Genève, Switzerland

Targeted Memory Reactivation During REM Sleep in Patients With Social Anxiety Disorder

Not Applicable

Completed

Conditions: Sleep
Social Anxiety Disorder

Interventions: Behavioral: Exposure Therapy
Behavioral: Exposure Therapy and Targeted memory reactivation during REM sleep

First Posted Date: 2022-03-02

Last Posted Date: 2022-03-14

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 51

Registration Number: NCT05261659

Locations: 🇨🇭
Center for Sleep Medicine, University Hospitals of Geneva, Geneva, Switzerland

Combined Treatment of Nightmares With Targeted Memory Reactivation and Imagery Rehearsal Therapy

Not Applicable

Completed

Conditions: Nightmares, REM-Sleep Type

Interventions: Behavioral: Imagery Rehearsal Therapy and Targeted memory reactivation during REM sleep
Behavioral: Imagery Rehearsal Therapy

First Posted Date: 2022-02-14

Last Posted Date: 2022-02-14

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 36

Registration Number: NCT05237778

Locations: 🇨🇭
Center for Sleep Medicine, University Hospitals of Geneva, Geneva, Switzerland

Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines

Phase 2

Conditions: Vaccine-Preventable Diseases
Pertussis

Interventions: Drug: Pertagen®
Drug: Revaxis®

First Posted Date: 2022-01-18

Last Posted Date: 2022-01-18

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 100

Registration Number: NCT05193734

Locations: 🇨🇭
University of Geneva, Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy